Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free KLDO Stock Alerts

Kaleido Biosciences (KLDO) Competitors

Kaleido Biosciences logo
Compare

KLDO vs. MVLA, PRST, KBNT, AISPW, and APCXW

Should you buy Kaleido Biosciences stock or one of its competitors? Kaleido Biosciences's main competitors and comparable companies include Movella (MVLA), Presto Automation (PRST), Kubient (KBNT), Airship AI (AISPW), and AppTech Payments (APCXW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Kaleido Biosciences compare to Movella?

Kaleido Biosciences (NASDAQ:KLDO) and Movella (NASDAQ:MVLA) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

81.6% of Kaleido Biosciences shares are owned by institutional investors. Comparatively, 40.9% of Movella shares are owned by institutional investors. 9.0% of Kaleido Biosciences shares are owned by company insiders. Comparatively, 20.0% of Movella shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Movella has lower revenue, but higher earnings than Kaleido Biosciences. Movella is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
Movella-$559K-0.03-$220K-$0.62N/A

In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Movella'saverage media sentiment score.

Company Overall Sentiment
Kaleido Biosciences Neutral
Movella Neutral

Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market. Comparatively, Movella has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Movella N/A N/A N/A

Summary

Movella beats Kaleido Biosciences on 4 of the 7 factors compared between the two stocks.

How does Kaleido Biosciences compare to Presto Automation?

Presto Automation (NASDAQ:PRST) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment.

In the previous week, Presto Automation's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score.

Company Overall Sentiment
Presto Automation Neutral
Kaleido Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
Presto AutomationN/A N/A N/A
Kaleido Biosciences N/A N/A N/A

20.9% of Presto Automation shares are owned by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are owned by institutional investors. 10.0% of Presto Automation shares are owned by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Presto Automation has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Presto Automation$19.05M0.00-$34.48M-$1.23N/A
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A

Presto Automation has a beta of -3.45, meaning that its stock price is 445% less volatile than the broader market. Comparatively, Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market.

Summary

Presto Automation beats Kaleido Biosciences on 4 of the 7 factors compared between the two stocks.

How does Kaleido Biosciences compare to Kubient?

Kubient (NASDAQ:KBNT) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Kubient has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market. Comparatively, Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
KubientN/A N/A N/A
Kaleido Biosciences N/A N/A N/A

Kubient has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kubient$1.17M0.00-$13.62MN/AN/A
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A

13.9% of Kubient shares are held by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are held by institutional investors. 22.3% of Kubient shares are held by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Kubient's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score.

Company Overall Sentiment
Kubient Neutral
Kaleido Biosciences Neutral

Summary

Kubient beats Kaleido Biosciences on 4 of the 6 factors compared between the two stocks.

How does Kaleido Biosciences compare to Airship AI?

Kaleido Biosciences (NASDAQ:KLDO) and Airship AI (NASDAQ:AISPW) are both technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Airship AI N/A N/A N/A

Airship AI has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
Airship AI$18.15MN/AN/AN/AN/A

In the previous week, Airship AI had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Airship AI and 0 mentions for Kaleido Biosciences. Airship AI's average media sentiment score of 1.87 beat Kaleido Biosciences' score of 0.00 indicating that Airship AI is being referred to more favorably in the news media.

Company Overall Sentiment
Kaleido Biosciences Neutral
Airship AI Very Positive

81.6% of Kaleido Biosciences shares are owned by institutional investors. 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Airship AI beats Kaleido Biosciences on 3 of the 5 factors compared between the two stocks.

How does Kaleido Biosciences compare to AppTech Payments?

Kaleido Biosciences (NASDAQ:KLDO) and AppTech Payments (NASDAQ:APCXW) are both technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
AppTech Payments N/A N/A N/A

AppTech Payments has lower revenue, but higher earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
AppTech Payments$276KN/AN/AN/AN/A

In the previous week, AppTech Payments had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for AppTech Payments and 0 mentions for Kaleido Biosciences. AppTech Payments' average media sentiment score of 1.08 beat Kaleido Biosciences' score of 0.00 indicating that AppTech Payments is being referred to more favorably in the news media.

Company Overall Sentiment
Kaleido Biosciences Neutral
AppTech Payments Positive

Summary

Kaleido Biosciences beats AppTech Payments on 3 of the 5 factors compared between the two stocks.

Get Kaleido Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KLDO vs. The Competition

Export
MetricKaleido BiosciencesSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$4K$15.92B$30.54B$13.06B
Dividend YieldN/A3.43%2.73%10.45%
P/E Ratio0.00127.8975.6025.31
Price / SalesN/A1,307.04601.6674.79
Price / CashN/A48.9853.7250.90
Price / BookN/A7.339.606.24
Net Income-$95.48M$436.26M$681.19M$347.71M

Kaleido Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLDO
Kaleido Biosciences
N/AN/AN/AN/A$4K$1.10MN/A80
MVLA
Movella
N/A$0.00
+50.0%		N/A+0.0%$15K-$559KN/A3
PRST
Presto Automation
N/AN/AN/AN/A$10K$19.05MN/A4
KBNT
Kubient
N/AN/AN/AN/A$1K$1.17MN/A40
AISPW
Airship AI
N/A$0.46
-8.0%		N/A-73.1%$0.00$18.15MN/A47

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:KLDO) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel